Medicare Reimbursement Changes May Lead to More Antibiotic Use
With improved drug coverage under Medicare Part D, the use of antibiotics by beneficiaries—particularly brand name, new, and more expensive drugs—is on the upswing, according to a study from the University of Pittsburgh Graduate School of Medicine.
In particular, the study, which appears in the Aug. 9/23 issue of the Archives of Internal Medicine, suggests recent Medicare reimbursement changes in drug coverage improved, for instance, the use of antibiotics for pneumonia. However, this also could lead to unnecessary spending for expensive broad spectrum antibiotics and possible overuse of inappropriate antibiotics.
"Overuse of antibiotics is a common and important problem that can lead to medical complications and drug resistance," said the study's lead author, Yuting Zhang, PhD, assistant professor of health economics at the University of Pittsburgh Graduate School of Public Health.
The study reviewed about 35,000 Medicare beneficiaries and examined their use of antibiotics two years before and after the implementation in 2006 of Medicare Part D, which reduced out of pocket drug spending between 13% and 23%. Increases were seen most among those seniors who did not previously have drug coverage.
- Primary Care Docs Average More Hospital Revenue Than Specialists
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- How Chargemaster Data May Affect Hospital Revenue
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
- Building a Better Healthcare Board
- Hospital Pricing Irks Nurses; More Jobs, Less Pay
- ED Physicians Key to Half of Hospital Admissions
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Quiet ORs Better for Patient Safety
- CMS Releases Hospital Pricing Data